July 01, 2024
CBD and Metformin Found to Alleviate Behavioral Issues in Autism-Linked Syndromes
Recent research presented at the Federation of European Neuroscience Societies (FENS) Forum 2024 has found that cannabidiol (CBD) and metformin can alleviate behavioral difficulties in mouse models of Fragile X and Phelan-McDermid syndromes, both of which are linked to autism spectrum disorder (ASD).
October 19, 2020
UC Davis Creates 4-Year Program for Individuals with Intellectual Disabilities
Through a $2.1 million grant from the U.S. Department of Education, UC Davis’ MIND Institute and Office of Diversity, Equity and Inclusion is establishing a four-year college program for students with intellectual disabilities. This new program is expected to start in the fall 2021 with 12 students who hold diagnoses such as autism, Down’s syndrome, fragile X syndrome and other neurodevelopmental disabilities.
